Cargando…
Long-Term Non-Invasive Treatment via Intranasal Administration of Nerve Growth Factor Protects the Human Brain in Frontotemporal Dementia associated with Corticobasal Syndrome: A Pilot Study
BACKGROUND: Nerve growth factor (NGF) is known for playing a critical protective role on a number of brain neurons in mammals, including humans. NGF can be delivered to the CNS via nasal route and has a neuroprotective action in case of neurodegenerative diseases. OBJECTIVE: The aim of this study is...
Autores principales: | de Bellis, Alberto, de Bellis, Massimo, Aloe, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159695/ https://www.ncbi.nlm.nih.gov/pubmed/30480250 http://dx.doi.org/10.3233/ADR-180055 |
Ejemplares similares
-
Intranasal nerve growth factor bypasses the blood-brain barrier and affects spinal cord neurons in spinal cord injury
por: Aloe, Luigi, et al.
Publicado: (2014) -
White Matter Tract Damage in the Behavioral Variant of Frontotemporal and Corticobasal Dementia Syndromes
por: Tovar-Moll, Fernanda, et al.
Publicado: (2014) -
The Clinical Overlap between the Corticobasal Degeneration Syndrome and Other Diseases of the Frontotemporal Spectrum: Three Case Reports
por: Raggi, Alberto, et al.
Publicado: (2007) -
Corticobasal degeneration and corticobasal syndrome: A review
por: Constantinides, Vasilios C., et al.
Publicado: (2019) -
Frontotemporal dementia
por: Warren, Jason D, et al.
Publicado: (2013)